- Home
- SGN vs ACON Comparison
SGN vs ACON Comparison
Compare SGN & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGN
- ACON
- Stock Information
- Founded
- SGN 2019
- ACON 2008
- Country
- SGN United States
- ACON United States
- Employees
- SGN N/A
- ACON N/A
- Industry
- SGN
- ACON Retail: Computer Software & Peripheral Equipment
- Sector
- SGN
- ACON Technology
- Exchange
- SGN Nasdaq
- ACON Nasdaq
- Market Cap
- SGN 3.8M
- ACON 4.5M
- IPO Year
- SGN 2023
- ACON 2022
- Fundamental
- Price
- SGN $1.89
- ACON $7.81
- Analyst Decision
- SGN
- ACON Buy
- Analyst Count
- SGN 0
- ACON 2
- Target Price
- SGN N/A
- ACON $481.00
- AVG Volume (30 Days)
- SGN 193.4K
- ACON 8.1K
- Earning Date
- SGN 11-13-2025
- ACON 11-13-2025
- Dividend Yield
- SGN N/A
- ACON N/A
- EPS Growth
- SGN N/A
- ACON N/A
- EPS
- SGN N/A
- ACON N/A
- Revenue
- SGN $391,126.00
- ACON $62,948.00
- Revenue This Year
- SGN N/A
- ACON $145.39
- Revenue Next Year
- SGN N/A
- ACON $145.45
- P/E Ratio
- SGN N/A
- ACON N/A
- Revenue Growth
- SGN N/A
- ACON 16.68
- 52 Week Low
- SGN $0.44
- ACON $6.20
- 52 Week High
- SGN $36.70
- ACON $3,499.51
- Technical
- Relative Strength Index (RSI)
- SGN 60.63
- ACON 64.12
- Support Level
- SGN $1.78
- ACON $7.51
- Resistance Level
- SGN $2.10
- ACON $7.84
- Average True Range (ATR)
- SGN 0.14
- ACON 0.25
- MACD
- SGN 0.03
- ACON 0.07
- Stochastic Oscillator
- SGN 74.60
- ACON 97.07
About SGN Signing Day Sports Inc.
Signing Day Sports Inc is a technology company developing and operating platforms aiming to allow significantly more student-athletes to go to college and continue playing sports. Its platform Signing Day Sports is a digital ecosystem to help athletes get discovered and recruited by coaches and recruiters across the country. It currently fully supports football and baseball, and it plans to expand the Signing Day Sports platform to include additional sports.
About ACON Aclarion Inc.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.